Literature DB >> 22777316

Difference of antihypertensive prescribing between office- and hospital-based clinics in Taiwan.

Wei-Liang Chen1, Tung-Wei Kao, Chung-Ching Wang, Yaw-Wen Chang, Li-Wei Wu, Mark L Wahlqvist, Chih-Chieh Chou.   

Abstract

BACKGROUND: The geographical location and medical facility may affect the pattern of antihypertensive prescriptions. Information regarding the correlation between the prescription and health care faculties in different geographical locations was lacking.
OBJECTIVE: The aim of this study was to compare differences in the prescribing of antihypertensives between hospital-based clinics (hospital arm) and office-based clinics (office arm) in different geographical locations in Taiwan.
METHOD: We collected data from the National Health Insurance database of Taiwan to carry out a population-based, retrospective cohort analysis of 3,218,794 patients newly diagnosed with hypertension in the period January 1, 1997 to December 31, 2004. Eligible participants were classified into either of two groups based on the level of health care faculty: hospital arm and office arm. The covariates composed of age, gender, antihypertensive regimens, urbanization status, comorbidity, and Charlson comorbidity index.
RESULTS: There were 2,028,784 cases (63.0 %) for the hospital arm and 1,190,010 (37 %) for the office arm. In the hospital-based arm, there were 168,933 (8.3 %) patients diagnosed with diabetes mellitus, 166,110 (8.2 %) patients diagnosed with coronary artery disease, 147,465 (7.3 %) patients diagnosed with cerebrovascular accident, 86,866 (4.3 %) patients diagnosed with chronic kidney disease, 74,525 (3.7 %) patients diagnosed with benign prostatic hyperplasia, 55,517 (2.7 %) patients diagnosed with congestive heart failure. The all comorbidities in the hospital arm had significantly higher proportions than those in the office arm (p < 0.001). The Charlson comorbidity index in the hospital arm was higher than that in the office arm (p < 0.001). Physicians who practiced in the office arm prescribed polytherapy less often than those in the hospital arm (OR = 0.68, 95 % CI: 0.67-0.68). For overall urbanization status, the adjusted OR of polytherapy prescriptions in the aging city (OR = 1.08, 95 % CI: 1.05-1.12) was higher than other type cities. The highest urbanization-specific OR of polytherapy prescriptions was observed for highly urbanized city in the hospital arm (OR = 1.20, 95 % CI: 1.18-1.23) and aging city in the office arm (OR = 1.42, 95 % CI: 1.21-1.67). In the both arm, patients with lower CCI showed decreased risk of polytherapy prescription.
CONCLUSION: The antihypertensive prescriptions in the clinical practices were different between the hospital arm and the office arm in the different health care, comorbidity, and urbanization status. During the study period, the proportion of antihypertensive polytherapy had declined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777316     DOI: 10.1007/s11096-012-9664-9

Source DB:  PubMed          Journal:  Int J Clin Pharm


  20 in total

1.  The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1988-05

2.  Family physicians' and general practitioners' approaches to drug management of diabetic hypertension in primary care.

Authors:  Khalid A J Al Khaja; Reginald P Sequeira; Vijay S Mathur; Awatif H H Damanhori; Abdul Wahab M Abdul Wahab
Journal:  J Eval Clin Pract       Date:  2002-02       Impact factor: 2.431

3.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

4.  Long-term and short-term changes in antihypertensive prescribing by office-based physicians in the United States.

Authors:  Randall S Stafford; Veronica Monti; Curt D Furberg; Jun Ma
Journal:  Hypertension       Date:  2006-06-19       Impact factor: 10.190

5.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

6.  Trends in the use of lipid-lowering drugs by outpatients with diabetes in Taiwan, 1997-2003.

Authors:  Chi-Wen Chiang; Hui-Fen Chiu; Chi-Yu Chen; Hsin-Lung Wu; Chun-Yuh Yang
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-01       Impact factor: 2.890

7.  Changes in drug prescription utilization for diabetic and hypertensive outpatients after initiation of the National Health Insurance's Global Budget Program in Taiwan.

Authors:  Chih-Chieh Chou; Kun-Yi Hu; Ni-Ren Wu; Yeong-Huang Cheng; Ching-Hui Loh; Ming-Kung Yeh
Journal:  Med Sci Monit       Date:  2008-05

8.  Patterns of ambulatory care utilization in Taiwan.

Authors:  Tzeng-Ji Chen; Li-Fang Chou; Shinn-Jang Hwang
Journal:  BMC Health Serv Res       Date:  2006-05-04       Impact factor: 2.655

9.  International variation in prescribing antihypertensive drugs: its extent and possible explanations.

Authors:  Atle Fretheim; Andrew D Oxman
Journal:  BMC Health Serv Res       Date:  2005-03-11       Impact factor: 2.655

10.  Antihypertensive medication prescription patterns and time trends for newly-diagnosed uncomplicated hypertension patients in Taiwan.

Authors:  Pang-Hsiang Liu; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2008-06-18       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.